Beta Drugs Limited — Call Transcript 2025

Nov 7, 2025

==> picture [519 x 103] intentionally omitted <==

BDL/PKL/SEC/2025 7[th] November, 2025

To

The Listing Department National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor Plot no. C/l, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051.

Dear Sir/Madam,

Sub : Audio Recording of Analysts and Investors Call pertaining to the Financial Results for the half year ended 30[th] September, 2025.

Ref : Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

With reference to the above referred Regulation and in continuation of our letter dated 3[rd] November, 2025 regarding schedule of analysts and investors conference call, please find below the link to the audio recording of said analysts and investors call on the Unaudited Standalone and Consolidated Financial Results of the Company for the half year ended 30[th] September, 2025 held on Friday, 7[th] November, 2025. The Results were approved by the Board at its Meeting held on Thursday, 6[th] November, 2025.

Link to access aforesaid Analysts and Investors conference call recording:

https://www.betadrugslimited.com/wp-content/uploads/2025/11/Investor-Concall-Recording-Dated07.11.2025.mp3

You are requested to take the same on record.

Thanking You Your’s faithfully For Beta Drugs Ltd.

==> picture [122 x 48] intentionally omitted <==

Rajni Brar Company Secretary

==> picture [490 x 67] intentionally omitted <==